Idiopathic hemochromatosis with the mutation of Ala176Val heterozygous for HFE gene

被引:8
作者
Imanishi, H [1 ]
Liu, WD [1 ]
Cheng, JD [1 ]
Ikeda, N [1 ]
Amuro, Y [1 ]
Hada, T [1 ]
机构
[1] Hyogo Coll Med, Dept Internal Med 3, Nishinomiya, Hyogo 6638501, Japan
关键词
C282Y; RT-PCR; point mutation;
D O I
10.2169/internalmedicine.40.479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most patients with hereditary hemochromatosis are homozygous for C282Y in the HFE gene in populations of Celtic origin, but the genetic cause of this disease is unknown in Japan because of its rarity. A 48-year-old Japanese patient was recently diagnosed with idiopathic hemochromatosis, Analysis of the entire coding region of the patient's HFE by RT-PCR showed a heterozygous nucleotide substitution at nucleotide 527 from C to T, which resulted in A176V amino acid substitution. Another mutation at nucleotide 942 from T to C was observed, but this was a nonsense mutation. C282Y and another mutation, H63D, were not found in the patient. The mutation may have a possible role on the cause of hemochromatosis in this Japanese case.
引用
收藏
页码:479 / 483
页数:5
相关论文
共 15 条
[1]   HLA-H and associated proteins in patients with hemochromatosis [J].
Beutler, E ;
West, C ;
Gelbart, T .
MOLECULAR MEDICINE, 1997, 3 (06) :397-402
[2]   A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria [J].
Brissot, P ;
Moirand, R ;
Jouanolle, AM ;
Guyader, D ;
Le Gall, JY ;
Deugnier, Y ;
David, V .
JOURNAL OF HEPATOLOGY, 1999, 30 (04) :588-593
[3]   Clinical and biochemical abnormalities in people heterozygous for hemochromatosis [J].
Bulaj, ZJ ;
Griffen, LM ;
Jorde, LB ;
Edwards, CQ ;
Kushner, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24) :1799-1805
[4]  
Carella M, 1997, AM J HUM GENET, V60, P828
[5]   Polymorphisms in the HFE gene [J].
Douabin, V ;
Moirand, R ;
Jouanolle, AM ;
Brissot, P ;
Le Gall, JY ;
Deugnier, Y ;
David, V .
HUMAN HEREDITY, 1999, 49 (01) :21-26
[6]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[7]  
Hattori K., 1997, Hepatology, V26, p522A
[8]  
Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249
[9]   Haemochromatosis and HLA-H [J].
Jouanolle, AM ;
Gandon, G ;
Jezequel, P ;
Blayau, M ;
Campion, ML ;
Yaouanq, J ;
Mosser, J ;
Fergelot, P ;
Chauvel, B ;
Bouric, P ;
Carn, G ;
Andrieux, N ;
Gicquel, I ;
LeGall, JY ;
David, V .
NATURE GENETICS, 1996, 14 (03) :251-252
[10]   Global prevalence of putative haemochromatosis mutations [J].
MerryweatherClarke, AT ;
Pointon, JJ ;
Shearman, JD ;
Robson, KJH .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (04) :275-278